With offices in the US, UK and the Netherlands, Lightpoint Medical is an 8 year old firm intent on becoming the world technology leader in targeted cancer surgery. Addressing the felt need for surgeons to be able during surgery - and in real time - to differentiate between cancerous and non-cancerous tissue, the companys technology has the potential to detect cancer in real time during surgery, thereby enabling surgeons to remove the cancerous tissue while sparing healthy tissue. The technology is based on administering the patient a cancer-targeted imaging drug and then detecting the cancer live during surgery. Since the founding of the company, Lightpoint has achieved clinical trial data in multiple cancer types, regulatory clearance, and is well on its way to transforming the practice of cancer surgery.
